Skip to Main Content

Author Details

Donald W Parsons
Texas Children's Hospital
1996
95
44
PMIDPaper TitleJournal TitlePublished Year
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
36335802The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science.Neoplasia2023
37430453Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics.Pediatr Blood Cancer2023
37366551Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.Pediatr Hematol Oncol2023
37228094Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.J Natl Cancer Inst2023
36595372Views of Adolescents and Young Adults with Cancer and Their Oncologists Toward Patients' Participation in Genomic Research.J Adolesc Young Adult Oncol2023
37366551Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.Pediatr Hematol Oncol2023
37228094Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.J Natl Cancer Inst2023
37430453Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics.Pediatr Blood Cancer2023
36595372Views of Adolescents and Young Adults with Cancer and Their Oncologists Toward Patients' Participation in Genomic Research.J Adolesc Young Adult Oncol2023
34280401Physician-Scientist Training and Programming in Pediatric Residency Programs: A National Survey.J Pediatr2022
35713195Clinical and molecular features of pediatric cancer patients with Lynch syndrome.Pediatr Blood Cancer2022
35487348A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels.J Mol Diagn2022
35363510Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.J Clin Oncol2022
35353553Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.J Clin Oncol2022
34280401Physician-Scientist Training and Programming in Pediatric Residency Programs: A National Survey.J Pediatr2022
35026696Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.Cancer Genet2022
35182954Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma.Transl Oncol2022
35178549TRK inhibition for pediatric and adult central nervous system tumors: Early promise and future questions.Neuro Oncol2022
35353553Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.J Clin Oncol2022
35363510Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial.J Clin Oncol2022
35487348A Validation Framework for Somatic Copy Number Detection in Targeted Sequencing Panels.J Mol Diagn2022
35713195Clinical and molecular features of pediatric cancer patients with Lynch syndrome.Pediatr Blood Cancer2022
35182954Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma.Transl Oncol2022
35178549TRK inhibition for pediatric and adult central nervous system tumors: Early promise and future questions.Neuro Oncol2022
35026696Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.Cancer Genet2022
33009870Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma.Pediatr Blood Cancer2021
33741710ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.Cancer Discov2021
34207141Pediatric Oncologists' Experiences Returning and Incorporating Genomic Sequencing Results into Cancer Care.J Pers Med2021
34086347Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.J Pathol2021
33009870Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma.Pediatr Blood Cancer2021
34651095Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an <i>NTRK2</i> Fusion: The Impact of Integrated Genomic Profiling.JCO Precis Oncol2021
33741710ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.Cancer Discov2021
34651095Durable Response to Larotrectinib in a Child With Histologic Diagnosis of Recurrent Disseminated Ependymoma Discovered to Harbor an <i>NTRK2</i> Fusion: The Impact of Integrated Genomic Profiling.JCO Precis Oncol2021
34207141Pediatric Oncologists' Experiences Returning and Incorporating Genomic Sequencing Results into Cancer Care.J Pers Med2021
34086347Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.J Pathol2021
32393959Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.Neuro Oncol2020
32179872Fixing the leaky pipeline: identifying solutions for improving pediatrician-scientist training during pediatric residency.Pediatr Res2020
32393959Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report.Neuro Oncol2020
31757314Precision Medicine in Pediatric Oncology.Surg Oncol Clin N Am2020
32876512Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in <i>KMT2A</i>-rearranged leukemia: a case series.Leuk Lymphoma2020
32843649Inferring clonal composition from multiple tumor biopsies.NPJ Syst Biol Appl2020
31757314Precision Medicine in Pediatric Oncology.Surg Oncol Clin N Am2020
32876512Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in <i>KMT2A</i>-rearranged leukemia: a case series.Leuk Lymphoma2020
32843649Inferring clonal composition from multiple tumor biopsies.NPJ Syst Biol Appl2020
32179872Fixing the leaky pipeline: identifying solutions for improving pediatrician-scientist training during pediatric residency.Pediatr Res2020
30581014Agents of empathy: How medical interpreters bridge sociocultural gaps in genomic sequencing disclosures with Spanish-speaking families.Patient Educ Couns2019
31645346Novel <i>PDGFRB</i> rearrangement in multifocal infantile myofibromatosis is tumorigenic and sensitive to imatinib.Cold Spring Harb Mol Case Stud2019
30581014Agents of empathy: How medical interpreters bridge sociocultural gaps in genomic sequencing disclosures with Spanish-speaking families.Patient Educ Couns2019
30482469Exome sequencing disclosures in pediatric cancer care: Patterns of communication among oncologists, genetic counselors, and parents.Patient Educ Couns2019
  • 1 - 50 of 190

Recommended Authors

College of Medicine, The Ohio State University
Career Start Year 2017
Number of shared co-authors 4
National Cancer Institute
Career Start Year 2013
Number of shared co-authors 32
Graduate School of Medicine, Kyoto University
Career Start Year 2012
Number of shared co-authors 28
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2010
Number of shared co-authors 44
Washington University in St Louis School of Medicine
Career Start Year 2010
Number of shared co-authors 8
Nationwide Children's Hospital
Career Start Year 2009
Number of shared co-authors 6
Children's Hospital Los Angeles
Career Start Year 2009
Number of shared co-authors 11
National Cancer Institute
Career Start Year 2009
Number of shared co-authors 26
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 24
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 15
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2008
Number of shared co-authors 46
Dana-Farber Cancer Institute
Career Start Year 2008
Number of shared co-authors 43
National Institutes of Health
Career Start Year 2007
Number of shared co-authors 17
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2006
Number of shared co-authors 69
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 15
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 25
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 65
University of California san francisco
Career Start Year 2003
Number of shared co-authors 44
St Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 31
SIREDO Oncology Center, Institut Curie Hospital, and Universite de Paris
Career Start Year 2001
Number of shared co-authors 36
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 21
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 40
Children's Hospital of Philadelphia
Career Start Year 2000
Number of shared co-authors 17
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 26
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 84
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 48
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 26
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 48
The Hospital for Sick Children
Career Start Year 1980
Number of shared co-authors 63
Hospital for Sick Children
Career Start Year 1976
Number of shared co-authors 65

Collaborators

Baylor College of Medicine
Co-authored papers 31
Texas Children's Hospital and Baylor College of Medicine
Co-authored papers 20
Co-authored papers 19
Co-authored papers 17
Co-authored papers 17
Texas Children's Cancer Center, Texas Children's Hospital
Co-authored papers 16
Baylor College of Medicine.
Co-authored papers 13
Co-authored papers 12
Dana Farber Cancer Institute.
Co-authored papers 12
Texas Children's Cancer Center, Baylor College of Medicine
Co-authored papers 12
Baylor College of Medicine
Co-authored papers 11
Baylor College of Medicine
Co-authored papers 10
Baylor College of Medicine
Co-authored papers 9
Baylor College of Medicine, Texas Children's Hospital
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
National Human Genome Research Institute, US National Institutes of Health
Co-authored papers 7
Co-authored papers 7
Baylor College of Medicine.
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Zucker School of Medicine at Hofstra/Northwell, and Lenox Hill Hospital
Co-authored papers 6
Baylor College of Medicine
Co-authored papers 5
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Medical Ethics and Health Policy, University of Pennsylvania
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5